- Efficacy of Over the Counter (OTC) Povidone-Ioldine 5% for Treatment of Acute or Chronic BlepharitisCondition: Blepharitis
Interventions: Drug: povidone iodine; Drug: Povidone-Iodine; Drug: Azithromycin; Drug: tobramycin-dexmethasone
Sponsors: Southern California Institute for Research and Education; Southern California Institute for Research and Education
Recruiting - verified March 2012 - Conditions: Snoring; Strep Throat
Interventions: Other: No postoperative antibiotic; Drug: Amoxicillin; Drug: Amoxicillin/clavulanate potassium; Drug: Azithromycin; Drug: Cefaclor; Drug: Cephalexin; Drug: Cefdinir; Drug: Clindamycin
Sponsors: University of Missouri-Columbia; University of Missouri-Columbia
Recruiting - verified March 2012 - Condition: RSV Bronchiolitis
Intervention: Drug: Azithromycin
Sponsors: Washington University School of Medicine; Washington University School of Medicine
Recruiting - verified December 2011 - Condition: Endometritis
Intervention: Drug: Azithromycin
Sponsors: University of Alabama at Birmingham; University of Alabama at Birmingham
Recruiting - verified April 2012 - Condition: Blepharitis
Interventions: Drug: ISV-502; Drug: Azasite; Drug: Dexamethasone; Other: Vehicle
Sponsors: InSite Vision; InSite Vision
Recruiting - verified April 2012 - Condition: Gastroparesis
Interventions: Drug: Erythromycin; Drug: Azithromycin
Sponsors: University of Florida; University of Florida
Recruiting - verified March 2012 - Condition: Bronchiolitis Obliterans
Interventions: Drug: fluticasone propionate; Drug: montelukast sodium; Procedure: pulmonary function testing; Other: questionnaire administration; Procedure: quality-of-life assessment; Other: laboratory biomarker analysis; Genetic: protein analysis; Drug: azithromycin
Sponsors: Fred Hutchinson Cancer Research Center; Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium; National Cancer Institute (NCI)
Recruiting - verified March 2012 - Conditions: Endometritis; Wound Infection; Abscess; Surgical Site Infection
Interventions: Drug: Azithromycin; Drug: Placebo
Sponsors: University of Alabama at Birmingham; Alan Tita; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); University of Texas; University of North Carolina
Recruiting - verified March 2012 - Condition: Chlamydia
Interventions: Drug: ceftriaxone; Drug: Azithromycin
Sponsors: University of Pittsburgh; Thomas L. Cherpes, MD; National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified February 2012 - Condition: C. Trachomatis
Interventions: Drug: Azithromycin; Drug: Doxycycline
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified May 2012 - Condition: Gonococcal Infections
Interventions: Drug: Azithromycin; Drug: Gemifloxacin; Drug: Gentamicin
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified November 2011 - Condition: Systemic Inflammatory Response Syndrome
Intervention: Other: Azithromycin on admission - not enrolled in the RCT
Sponsors: Department of Veterans Affairs; Department of Veterans Affairs; Feinberg School of Medicine, Northwestern University; National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified April 2012 - Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: Azithromycin; Drug: Placebo
Sponsors: University of Alabama at Birmingham; University of Alabama at Birmingham; National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified January 2012
 |
Azithromycin Clinical Trials |
